Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1875 of 2051 entries
View as:

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Phase: N/A Priority: Normal
NCT ID: NCT03407144 Org: User:
Start: 04/09/18 End: 02/13/27 Due: 02/13/28

Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)

Phase: N/A Priority: Normal
NCT ID: NCT03631407 Org: User:
Start: 09/24/18 End: 06/08/21 Due: 06/08/22

To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)

Phase: N/A Priority: Normal
NCT ID: NCT00398099 Org: User:
Start: 07/31/05 End: 01/31/06 Due: 01/31/07

A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)

Phase: N/A Priority: Normal
NCT ID: NCT00705289 Org: User:
Start: 12/31/05 End: 09/30/08 Due: 09/30/09

A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)

Phase: N/A Priority: Normal
NCT ID: NCT01050283 Org: User:
Start: 07/31/10 End: 05/31/12 Due: 05/31/13

Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00762983 Org: User:
Start: 03/31/08 End: 02/28/09 Due: 02/28/10

A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)

Phase: N/A Priority: Normal
NCT ID: NCT01409213 Org: User:
Start: 08/31/09 End: 01/31/11 Due: 01/31/12

A Study to Test the Tolerability of an Investigational Electroporation Device in Healthy Adults (V930-001)

Phase: N/A Priority: Normal
NCT ID: NCT00721461 Org: User:
Start: 07/31/05 End: 10/31/05 Due: 10/31/06

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Phase: N/A Priority: Normal
NCT ID: NCT07033494 Org: User:
Start: 07/17/25 End: 09/01/29 Due: 09/01/30

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

Phase: N/A Priority: Normal
NCT ID: NCT03834519 Org: User:
Start: 05/02/19 End: 01/27/24 Due: 01/27/25

A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)

Phase: N/A Priority: Normal
NCT ID: NCT00112437 Org: User:
Start: 06/24/05 End: 01/20/16 Due: 01/20/17

A Study of Odanacatib When Administered to Adolescents and Young Adults Treated With Glucocorticoids (MK-0822-066)

Phase: N/A Priority: Normal
NCT ID: NCT01630616 Org: User:
Start: 03/12/13 End: 07/14/16 Due: 07/14/17

A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)

Phase: N/A Priority: Normal
NCT ID: NCT00874939 Org: User:
Start: 04/06/09 End: 04/20/09 Due: 04/20/10

A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)

Phase: N/A Priority: Normal
NCT ID: NCT01717313 Org: User:
Start: 12/05/12 End: 06/19/15 Due: 06/19/16

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)

Phase: N/A Priority: Normal
NCT ID: NCT01269658 Org: User:
Start: 12/31/10 End: 06/30/11 Due: 06/30/12

A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)

Phase: N/A Priority: Normal
NCT ID: NCT04168190 Org: User:
Start: 12/06/19 End: 07/12/21 Due: 07/12/22

Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)

Phase: N/A Priority: Normal
NCT ID: NCT04652700 Org: User:
Start: 03/15/21 End: 08/04/23 Due: 08/04/24

A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Phase: N/A Priority: Normal
NCT ID: NCT04732221 Org: User:
Start: 05/19/21 End: 07/02/24 Due: 07/02/25

Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)

Phase: N/A Priority: Normal
NCT ID: NCT02564211 Org: User:
Start: 10/26/15 End: 03/07/17 Due: 03/07/18

A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)

Phase: N/A Priority: Normal
NCT ID: NCT00424775 Org: User:
Start: 01/31/07 End: 03/31/07 Due: 03/31/08

Efficacy and Safety of Org 25969 Administered After Zemuron® (MK-8616-042)

Phase: N/A Priority: Normal
NCT ID: NCT03519867 Org: User:
Start: 08/01/04 End: 05/26/05 Due: 05/26/06

Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)

Phase: N/A Priority: Normal
NCT ID: NCT02362594 Org: User:
Start: 07/16/15 End: 07/31/26 Due: 07/31/27

Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)

Phase: N/A Priority: Normal
NCT ID: NCT00725725 Org: User:
Start: 07/23/08 End: 04/23/10 Due: 04/23/11

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Phase: N/A Priority: Normal
NCT ID: NCT00322361 Org: User:
Start: 05/31/06 End: 07/31/07 Due: 07/31/08

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

Phase: N/A Priority: Normal
NCT ID: NCT04029480 Org: User:
Start: 10/08/19 End: 04/11/25 Due: 04/11/26